1. Size and apolipoprotein composition are the main factors determining atherogenicity of triglyceride-rich particles

3. Apo C-III modulates VLDL

4. Apo C-III in apo B particles is atherogenic

5. Relationship between apo C-III in apo B containing lipoproteins and atherogenicity

6. PROCAM Study MI-Incidence according to LDL-cholesterol and triglycerides

7. PROCAM Study CHD risk according to LDL-C and TG increased TG confers raised CHD risk at all levels of LDL-C

8. HDL: an anti-atherogenic lipoprotein

9. HDL metabolism: 5 key genes

10. HDL: apo AI-rich particles

11. Apo A-I protects against atherosclerosis

12. Apo A-II protects against atherosclerosis The human apo A-II transgenic mouse model